£18k
+79%vs Mar 2024Active06862700Private limited companyMacclesfield
ANTIBODY APPLICATIONS LIMITED
Significant control: Turid Patricia Dinsmore (25–50%), Andrew John Dinsmore (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Antibody Applications Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Antibody Applications Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ANTIBODY APPLICATIONS LIMITED is an active private limited company (company number 06862700) incorporated on 30 March 2009, registered in Macclesfield. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of £18k and cash of £42k, with 3 employees on average. Net assets rose 79% on the prior period (£9,823).
Peer position · net assets
By net assets it sits in the upper half of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Mrs Turid Patricia Dinsmore
- owns 25–50% of shares
- Mr Andrew John Dinsmore
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 30 March 200917 yrs ago
- Next accounts due
- 31 December 2026in 63 days
- Confirmation statement due
- 13 April 2027in 166 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£42k
−55%vs Mar 2024Not reported
3
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £18k | £42k | £52k | — | — | — | 3 |
| 31 March 2024 | £9,823 | £95k | £11k | — | — | — | 3 |
Cash per employee£14kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £17,614 at 31 March 2025
- Net assets up 10% or more on the prior period+79.3% vs prior period
- Incorporated five or more years agoIncorporated 30 March 2009
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 166 days
- Next accounts duein 63 days
- Accounts period endNet assets £18k · small accounts
- Accounts period endNet assets £9,823 · small accounts
- Incorporated
08
Similar companies in Manchester
- DCN CORPORATION LIMITEDAshton-Under-Lyne · inc. Apr 2009
- SPHERITECH LIMITEDRuncorn · inc. Apr 2009
- BIOXYDYN LIMITEDManchester · inc. Mar 2009
- PREVENT BREAST CANCER TRADING COMPANY LIMITEDManchester · inc. Sept 2009
- INSTIL BIO (UK) LIMITEDMacclesfield · inc. Sept 2008
- APEX MOLECULAR LIMITEDAlderley Edge · inc. May 2008
All companies incorporated on 30 March 2009 · in Mar 2009.
09
Reminders for ANTIBODY APPLICATIONS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.